GSK3B and cancer: In the distant metastatic SCC samples, the invasive cancer cells at the new location demonstrated an overexpression of GSK3β in 87.5% (7/8) whereas only 12.5% (1/8) of samples showed an overexpression of GSK3α (p = 0.002) (Table 1 and Figure 3C (a to h)).